Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
04/02/2008 | EP1210357B1 Oligonucleotide n3'-p5' thiophosphoramidates: their synthesis and use |
04/02/2008 | CN101155830A Antibodies that bind to epha2 and methods of use thereof |
04/02/2008 | CN101155822A Aptamer therapeutics useful in the treatment of complement-related disorders |
04/02/2008 | CN101155821A Phosphoramidite activator for oligonucleotide synthesis |
04/02/2008 | CN100378223C Pylorus screw bacterium fenestra element having adhesion function |
04/02/2008 | CN100378121C Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
04/01/2008 | US7351819 Using oligonucleotides to detect viral nucleotide sequences in food; diagnosing food poisoning |
04/01/2008 | US7351818 Adjust efficiency translation of polypeptides; gene expression; vaccine; isolated Dna |
04/01/2008 | US7351817 For transfecting a plant cell |
04/01/2008 | US7351816 Nucleic acid encoding anti-IgE antibodies |
04/01/2008 | US7351815 Canine pre-proGHRH and mature GHRH genes |
04/01/2008 | US7351814 Olfactory receptor expression libraries and methods of making and using them |
04/01/2008 | US7351813 Expression vector coding heterologous protein for use in human therapeutics; for treatment of blood nd liver disorders |
04/01/2008 | US7351812 For selecting protein or nucleic acid molecule by linking mRNA, with known or unknown sequences, to its translated protein to form a cognate pair |
04/01/2008 | US7351811 Gene SCC-112 and diagnostic and therapeutic uses thereof |
04/01/2008 | US7351810 Polypeptides, polynucleotides and uses thereof |
04/01/2008 | US7351804 Antibodies against PRO4421 |
04/01/2008 | US7351802 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis |
04/01/2008 | US7351794 PRO1754 polypeptides |
04/01/2008 | US7351793 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
04/01/2008 | US7351789 For pharmaceuticals, diagnostics, biosensors and bioreactors |
04/01/2008 | US7351573 Transgenic cell comprising vetor coding cellulase protein for use in preparing biofuels, detergents, textile treatment and enhancing animal feeds |
04/01/2008 | US7351571 Process for the production of β-amino acids using acylase |
04/01/2008 | US7351569 Such as 4-(Indol-3-ylmethyl)-4-hydroxy-2-oxoglutarate from indole pyruvic acid and pyruvic acid (and/or oxaloacetic acid) by aldolase derived from Pseudomonas, Erwinia, Flavobacterium, and/or Xanthomonas |
04/01/2008 | US7351566 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
04/01/2008 | US7351565 Plant caffeic acid 3-O-methyltransferase homologs |
04/01/2008 | US7351564 SQS gene |
04/01/2008 | US7351562 Ribulose 1,5-bisphosphate carboxylase/oxygenase polypeptides and related polynucleotides |
04/01/2008 | US7351560 Glycerol-3-phosphate phosphatase and glycerol-3-phosphate dehydrogenase from Candida albicans, genes encoding the same, vector and host cell containing the genes, and method for producing glycerol using the host cell |
04/01/2008 | US7351551 Adipocyte differentiation-associated gene and protein |
04/01/2008 | US7351550 Exoenzyme toxin of Aeromonas salmonicida, and uses thereof |
04/01/2008 | US7351545 Pre-treating breast cancer cells with an IGFBP-3 fragment or fusion protein that binds IGF-I or IGF-II for 24 hours prior to treating the cells with an apoptotic factor( paclitaxel, doxorubicin) and native-sequence human IGFBP-3 or fragment or fusion protein for determining enhancement of apoptosis |
04/01/2008 | US7351542 Methods of modulating tubulin deacetylase activity |
04/01/2008 | US7351538 Especially nucleic acids; at least three different emitters that together create an excitation signal configured to excite each of at least three fluorophores so that each emits a distinct emission signal within its respective emission bandwidth has an emission maximum separated by 60+ nm from others |
04/01/2008 | US7351537 Variants of cyan fluorescent protein with improved fluorescent properties |
04/01/2008 | US7351536 a transposon-like element specifically present in the rye genome but not present in the wheat genome, for the purpose of breading wheat exhibiting resistance to disease and environmental stress |
04/01/2008 | US7351535 Using cholesterol transport protein to identify modulators which enhance high density lipoprotein concentration in blood |
04/01/2008 | US7351532 Determining the identity mutations or single nucleotide polymorphisms (SNPs) in a genome by contacting with different oligonucleotide molecules to permit template dependent oligonucleotide ligation; only those oligonucleotides with a base that is complementary to the SNP will undergo ligation |
04/01/2008 | US7351531 Molecules capable of binding to telomere and the like and method with the use of the same |
04/01/2008 | US7351529 Methods for detecting genetic mosaicisms using arrays |
04/01/2008 | US7351528 Detection of preferential nucleotide sequences in sample; obtain sample incubate with probes, detect signal |
04/01/2008 | CA2408223C Plant brassinolide responsive genes and use thereof |
04/01/2008 | CA2316113C Method for nucleic acid purification using iodine |
04/01/2008 | CA2273064C Novel processes for amplifying nucleic acid, post-termination labeling process for nucleic acid sequencing and producing nucleic acid having decreased thermodynamic stability |
04/01/2008 | CA2175992C In situ modification and manipulation of stem cells of the central nervous system |
03/29/2008 | CA2604664A1 Method for detecting small oligonucleotides |
03/27/2008 | WO2008034866A2 Dbait and uses thereof |
03/27/2008 | WO2008005619A8 Shade tolerance in plants |
03/27/2008 | WO2007149550A3 Modulation of differentiation and cell function via fox01 and notch signaling |
03/27/2008 | WO2007140599A8 Assessment of risk for colorectal cancer |
03/27/2008 | WO2007107775A3 Preparation of oligonucleotides with photoswitchable properties |
03/27/2008 | WO2006128140A3 Gene methylation and expression |
03/27/2008 | WO2005117971A3 Regulators of angiogenesis |
03/27/2008 | WO2001022921A3 Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor |
03/27/2008 | US20080078004 Expression vector comprising nucleotide sequences coding serine/threonine kinase for use in generation stress tolerant maize |
03/27/2008 | US20080077372 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
03/27/2008 | US20080076913 Nucleosides; sodium/lithium/potassium peroxides as nucleophilic agents; solid phase synthesis |
03/27/2008 | US20080076912 Nucleic acid purification method |
03/27/2008 | US20080076911 Nucleic acid purification method |
03/27/2008 | US20080076910 Nucleic acid purification method |
03/27/2008 | US20080076909 Emulsion pcr and amplicon capture |
03/27/2008 | US20080076908 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders |
03/27/2008 | US20080076710 covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides treating Hepatitis-C virus |
03/27/2008 | US20080076674 Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding RNAs associated with cancer |
03/27/2008 | US20080076188 Luminescent compounds |
03/27/2008 | US20080076179 Sugar and lipid metabolism regulators in plants |
03/27/2008 | US20080076178 Methods for the production of plants resistant to HPPD herbicides |
03/27/2008 | US20080076174 Using site specific mutation as tool in directed protein evolution |
03/27/2008 | US20080076166 Method For Producing Polyunsaturated Fatty Acids In Transgenic Organisms |
03/27/2008 | US20080076164 Producing oils and/or lipids having high content of polyunsaturated fatty acids containing at least two double bonds in recombinant animals comprising ketoacyl-CoA reductase genes |
03/27/2008 | US20080076151 Compositions for controlling hair growth |
03/27/2008 | US20080076131 Preparing microarrays for replication of preferential nucleotide sequences; gene expression analysis |
03/27/2008 | US20080076127 Method and compositions for detecting helicobacter pylori |
03/27/2008 | US20080076126 Using blot analysis to monitor induction of monooxygenases in plants; enhancing biosynthesis of phenylpropanoids, alkaloids, terpenoids, lipids, cyanogenic glycosides, and glucosinolates |
03/27/2008 | US20080076124 Polypeptide comprising serine/threonine phosphatase activity for use as tool in identifying modulators for prevention and treatment of cell proliferative disorders |
03/27/2008 | US20080075736 Materials and methods for respiratory disease control in canines |
03/27/2008 | US20080075735 Demethylated and/or oxidized membrane DNA |
03/27/2008 | US20080075725 Novel Immunointeractive Molecules and uses Thereof |
03/27/2008 | US20080075724 Nucleotide sequeces coding protein for use in the detection, diagnosis and treatment cell proliferative, autoimmune diseases, inflammation and infection; biodrugs as antiinflammatory agents, antiproliferative agents |
03/27/2008 | US20080075723 Endotheliase 2 ligands |
03/27/2008 | US20080075722 detecting the presence of a protein marker in patient sample, using a reagent which specifically binds with protein; comparing the copy number of a minimal common region; anticarcinogenic biodrugs |
03/27/2008 | US20080075715 modified polypeptides, whereby the modification results in a reduced number of potential lymphocyte epitopes that provides a reduced propensity for the polypeptide to elicit an immune response upon administration to a human, but retain the ability to bind to CD52 antigens |
03/27/2008 | US20080072690 Penetrable cap |
03/27/2008 | CA2700360A1 In vivo transformation of pancreatic acinar cells into insulin-producing cells |
03/27/2008 | CA2664189A1 Compositions and methods related to protein displacement therapy for myotonic distrophy |
03/27/2008 | CA2663962A1 Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
03/27/2008 | CA2663819A1 Phytases, nucleic acids encoding them and methods for making and using them |
03/27/2008 | CA2663803A1 Rnai modulation of scap and therapeutic uses thereof |
03/27/2008 | CA2663601A1 Duplex oligonucleotide complexes and methods for gene silencing by rna interference |
03/27/2008 | CA2663581A1 Compositions and methods for inhibiting expression of the hamp gene |
03/27/2008 | CA2663055A1 Aldehyde tags, uses thereof in site-specific protein modification |
03/27/2008 | CA2663001A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
03/27/2008 | CA2662065A1 Dbait and uses thereof |
03/27/2008 | CA2651881A1 Oligonucleotide analogs having cationic intersubunit linkages |
03/26/2008 | EP1903112A2 Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family |
03/26/2008 | EP1902313A1 Trityl derivatives for enhancing mass spectrometry |
03/26/2008 | EP1902145A2 Methods of diagnosing and treating an inflammatory response |
03/26/2008 | EP1902142A2 3'modified oligonucleotides containing pseudoisocytosine nucleobase derivatives and applications thereof as primers or probes |
03/26/2008 | EP1902064A2 Normalization of samples for amplification reactions |
03/26/2008 | EP1465911B1 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |